185 related articles for article (PubMed ID: 24531225)
21. Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies.
Zhang X; Guo S; Chen C; Perez GR; Zhang C; Patanapongpibul M; Subrahmanyam N; Wang R; Keith J; Chen G; Dong Y; Zhang Q; Zhong Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2017 Sep; 137():263-279. PubMed ID: 28601720
[TBL] [Abstract][Full Text] [Related]
22. Anticancer potential of novel curcumin analogs towards castrate-resistant prostate cancer.
Chen S; Nimick M; Cridge AG; Hawkins BC; Rosengren RJ
Int J Oncol; 2018 Feb; 52(2):579-588. PubMed ID: 29207190
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
24. Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents.
Wang R; Chen C; Zhang X; Zhang C; Zhong Q; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
J Med Chem; 2015 Jun; 58(11):4713-26. PubMed ID: 25961334
[TBL] [Abstract][Full Text] [Related]
25. Design and Synthesis of Curcumin-Like Diarylpentanoid Analogues as Potential Anticancer Agents.
Qudjani E; Iman M; Davood A; Ramandi MF; Shafiee A
Recent Pat Anticancer Drug Discov; 2016; 11(3):342-51. PubMed ID: 27094172
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, characterization and in vitro anticancer activity of C-5 curcumin analogues with potential to inhibit TNF-α-induced NF-κB activation.
Anthwal A; Thakur BK; Rawat MS; Rawat DS; Tyagi AK; Aggarwal BB
Biomed Res Int; 2014; 2014():524161. PubMed ID: 25157362
[TBL] [Abstract][Full Text] [Related]
27. Facile synthesis of novel substituted aryl-thiazole (SAT) analogs via one-pot multi-component reaction as potent cytotoxic agents against cancer cell lines.
Mirza S; Asma Naqvi S; Mohammed Khan K; Salar U; Choudhary MI
Bioorg Chem; 2017 Feb; 70():133-143. PubMed ID: 28038777
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines.
Somers-Edgar TJ; Taurin S; Larsen L; Chandramouli A; Nelson MA; Rosengren RJ
Invest New Drugs; 2011 Feb; 29(1):87-97. PubMed ID: 19816657
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and assessment of the antioxidant and antitumor properties of asymmetric curcumin analogues.
Li Q; Chen J; Luo S; Xu J; Huang Q; Liu T
Eur J Med Chem; 2015 Mar; 93():461-9. PubMed ID: 25728027
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of Curcuminoids and Evaluation of Their Cytotoxic and Antioxidant Properties.
Lozada-García MC; Enríquez RG; Ramírez-Apán TO; Nieto-Camacho A; Palacios-Espinosa JF; Custodio-Galván Z; Soria-Arteche O; Pérez-Villanueva J
Molecules; 2017 Apr; 22(4):. PubMed ID: 28420097
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, antimalarial activity and cytotoxic potential of new monocarbonyl analogues of curcumin.
Manohar S; Khan SI; Kandi SK; Raj K; Sun G; Yang X; Calderon Molina AD; Ni N; Wang B; Rawat DS
Bioorg Med Chem Lett; 2013 Jan; 23(1):112-6. PubMed ID: 23218718
[TBL] [Abstract][Full Text] [Related]
32. Novel Curcumin Inspired Antineoplastic 1-Sulfonyl-4-Piperidones: Design, Synthesis and Molecular Modeling Studies.
Fawzy NG; Panda SS; Fayad W; El-Manawaty MA; Srour AM; Girgis AS
Anticancer Agents Med Chem; 2019; 19(8):1069-1078. PubMed ID: 30961509
[TBL] [Abstract][Full Text] [Related]
33. Structure-activity relationship of C5-curcuminoids and synthesis of their molecular probes thereof.
Yamakoshi H; Ohori H; Kudo C; Sato A; Kanoh N; Ishioka C; Shibata H; Iwabuchi Y
Bioorg Med Chem; 2010 Feb; 18(3):1083-92. PubMed ID: 20060305
[TBL] [Abstract][Full Text] [Related]
34. Curcumin inspired 2-chloro/phenoxy quinoline analogues: Synthesis and biological evaluation as potential anticancer agents.
Sri Ramya PV; Guntuku L; Angapelly S; Karri S; Digwal CS; Babu BN; Naidu VGM; Kamal A
Bioorg Med Chem Lett; 2018 Mar; 28(5):892-898. PubMed ID: 29429834
[TBL] [Abstract][Full Text] [Related]
35. Epigenetics Reactivation of Nrf2 in Prostate TRAMP C1 Cells by Curcumin Analogue FN1.
Li W; Pung D; Su ZY; Guo Y; Zhang C; Yang AY; Zheng X; Du ZY; Zhang K; Kong AN
Chem Res Toxicol; 2016 Apr; 29(4):694-703. PubMed ID: 26991801
[TBL] [Abstract][Full Text] [Related]
36. Syntheses and cytotoxic properties of the curcumin analogs 2,6-bis(benzylidene)-4-phenylcyclohexanones.
Davis R; Das U; Mackay H; Brown T; Mooberry SL; Dimmock JR; Lee M; Pati H
Arch Pharm (Weinheim); 2008 Jul; 341(7):440-5. PubMed ID: 18574852
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and antitumor evaluation of novel 5-methylpyrazolo[1,5-a]pyrimidine derivatives as potential c-Met inhibitors.
Luo G; Ma Y; Liang X; Xie G; Luo Y; Zha D; Wang S; Yu L; Zheng X; Wu W; Zhang C
Bioorg Chem; 2020 Nov; 104():104356. PubMed ID: 33142417
[TBL] [Abstract][Full Text] [Related]
38. Curcumin analog cytotoxicity against breast cancer cells: exploitation of a redox-dependent mechanism.
Sun A; Lu YJ; Hu H; Shoji M; Liotta DC; Snyder JP
Bioorg Med Chem Lett; 2009 Dec; 19(23):6627-31. PubMed ID: 19854644
[TBL] [Abstract][Full Text] [Related]
39. The natural product CCR5 antagonist anibamine and its analogs as anti-prostate cancer agents.
Haney KM; Zhang F; Arnatt CK; Yuan Y; Li G; Ware JL; Gewirtz DA; Zhang Y
Bioorg Med Chem Lett; 2011 Sep; 21(18):5159-63. PubMed ID: 21820898
[TBL] [Abstract][Full Text] [Related]
40. Design, Synthesis and Cytotoxicity Evaluation of New 3, 5-Disubstituted-2-Thioxoimidazolidinones.
Abdellatif KRA; Elbadawi MM; Elsaady MT; Abd El-Hafeez AA; Fujimura T; Kawamoto S; Khodair AI
Anticancer Agents Med Chem; 2018; 18(4):573-582. PubMed ID: 29189182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
